Mark Schactman

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

Adverse metabolic and cardiovascular consequences of circadian misalignment

Loss of cryptochrome reduces cancer risk in p53 mutant mice

Plasma P-selectin Predicts Long-term Cardiovascular Events in Hospitalized Patients with Suspected Coronary Artery Disease and Preserved Left Ventricular Function: A 10-Year Follow-Up Study

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Gender differences in management and outcome in non-ST-elevation acute coronary syndrome

Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction

Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins

Universal Definition of Myocardial Infarction

Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective

Dynamic PER repression mechanisms in the Drosophila circadian clock: from on-DNA to off-DNA

Acute Coronary Syndrome

The effect of aspirin on C-reactive protein as a marker of risk in unstable angina

Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina

Comparison of the prognostic value of C-Reactive protein and troponin I in patients with unstable angina pectoris

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Prospects for Cardiovascular Research

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes

C-Reactive Protein Levels and Outcomes after Statin Therapy

Epidemiological classification of acute myocardial infarction: time for a change?

Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin I

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

Impact of the troponin standard on the prevalence of acute myocardial infarction

Effects of Prior Aspirin and Anti-Ischemic Therapy on Outcome of Patients With Unstable Angina 11This study was supported by Biogen, Inc., Cambridge, Massachusetts. Manuscript received July 28, 1997; revised manuscript received and accepted December 1, 1997.

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb11Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON-A); Global Use of Strategies To Open occluded arteries in acute coronary syndromes (GUSTO-IIb).

Oxidative stress and cancer: An overview

Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial

The Diagnostic Utility of Cardiac Biomarkers in Dialysis Patients

Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris

Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain

Unstable Angina Pectoris

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram

Soluble CD40 Ligand in Acute Coronary Syndromes

Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators

The New Definition of Myocardial Infarction

Regulation of angiogenesis by hypoxia: role of the HIF system

Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery

Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

Guidelines for Percutaneous Coronary Interventions

Myonecrosis After Revascularization Procedures

Biomarkers in Acute Cardiac Disease

Diagnosis of ST-Elevation Myocardial Infarction in the Presence of Left Bundle Branch Block With the ST-Elevation to S-Wave Ratio in a Modified Sgarbossa Rule

Secondary prevention with folic acid: effects on clinical outcomes

Association Between Minor Elevations of Creatine Kinase-MB Level and Mortality in Patients With Acute Coronary Syndromes Without ST-Segment Elevation

Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock

Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

A clockwork web: circadian timing in brain and periphery, in health and disease

An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: Results from a randomized trial

Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns

Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Inflammation, Atherosclerosis, and Coronary Artery Disease

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Oxygen Sensing, Homeostasis, and Disease

Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures

Clinical implications of the new definition of myocardial infarction

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Biomarkers in Heart Failure

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes

Prognostic Value of Myeloperoxidase in Patients with Chest Pain

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Extracellular vesicles: Exosomes, microvesicles, and friends

Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis

Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes

Markers of Inflammation and Cardiovascular Disease

Label-free protein assay based on a nanomechanical cantilever array

Vibrational spectroscopic analysis of body fluids: avoiding molecular contamination using centrifugal filtration

Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease

Redefinition of Myocardial Infarction

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial Infarction

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

Dielectrophoresis-Assembled Zeolitic Imidazolate Framework Nanoparticle-Coupled Resonators for Highly Sensitive and Selective Gas Detection

Endogenous circadian rhythm in an index of cardiac vulnerability independent of changes in behavior

Cardiac Troponin T by Elecsys System and a Rapid ELISA: Analytical Sensitivity in Relation to the TropT (CardiacT) “Bedside” Test

Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Detecting Acute Coronary Syndrome in the Emergency Department With Cardiac Magnetic Resonance Imaging

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb

Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

Inflammation and Atherosclerosis

Electrochemiluminescence (ECL)

Unstable Angina

Control of skin cancer by the circadian rhythm

Regulation of apoptosis by the circadian clock through NF-κB signaling

Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes

Gold Nanoparticles in Chemical and Biological Sensing

National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Clinical End Points in Coronary Stent Trials

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Particulate Matter Air Pollution and Cardiovascular Disease

Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy

PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues

Air Pollution and ST-Segment Depression in Elderly Subjects

Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I

HIF-1 and human disease: one highly involved factor

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation

Generation and Detection of Reactive Oxygen Species in Photocatalysis

Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**

Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Circadian Variation in the Onset of Unstable Angina and Non-Q-Wave Acute Myocardial Infarction (The TIMI III Registry and TIMI IIIB)

Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes

The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.